3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas.

Jim ZhongVicki HuangSaumya S GurbaniKarthik RameshJ Scott CordovaEduard SchreibmannHui-Kuo G ShuJeffrey OlsonHui HanAlexander GiuffridaHyunsuk ShimBrent D Weinberg

Published in: Journal of neuro-oncology (2021)

MRSI in low-to-intermediate grade glioma patients is predictive of areas of subsequent recurrence. Larger studies are needed to determine if MRSI can be used to guide surgical and radiation treatment planning in these patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
high resolution
high grade
multiple sclerosis
radiation therapy
resting state